Exclusive

Publication

Byline

Location

US Patent Issued to Coastar Therapeutics on April 14 for "Process of making membrane lipid coated nanoparticles" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,574, issued on April 14, was assigned to Coastar Therapeutics Inc. (San Diego). "Process of making membrane lipid coated nanoparticles" wa... Read More


US Patent Issued to ANTECIP BIOVENTURES II on April 14 for "Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan" (New York Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,576, issued on April 14, was assigned to ANTECIP BIOVENTURES II LLC (New York). "Treatment of poor metabolizers of dextromethorphan with a... Read More


US Patent Issued to Ensysce Biosciences on April 14 for "Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof" (California Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,578, issued on April 14, was assigned to Ensysce Biosciences Inc. (La Jolla, Calif.). "Compositions comprising enzyme-cleavable prodrugs a... Read More


US Patent Issued to BASF AS on April 14 for "Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same" (Danish, Norwegian Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,580, issued on April 14, was assigned to BASF AS (Oslo, Norway). "Composition comprising a lipid compound, a triglyceride, and a surfactan... Read More


US Patent Issued to Aligos Therapeutics on April 14 for "Pyrrole compounds" (Belgian, American Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,582, issued on April 14, was assigned to Aligos Therapeutics Inc. (South San Francisco, Calif.). "Pyrrole compounds" was invented by Sandr... Read More


US Patent Issued to Yissum Research Development Company of The Hebrew University of Jerusalem, Bar-Ilan University on April 14 for "Indoline derivatives, compositions comprising them and uses thereof" (Israeli Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,584, issued on April 14, was assigned to Yissum Research Development Co. of The Hebrew University of Jerusalem Ltd. (Jerusalem) and Bar-Ila... Read More


US Patent Issued to Japan Science and Technology Agency on April 14 for "Inhibitor for V-ATPase activity, antibacterial agent, medicine, antibacterial method and screening method" (Japanese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,588, issued on April 14, was assigned to Japan Science and Technology Agency (Kawaguchi, Japan). "Inhibitor for V-ATPase activity, antibac... Read More


US Patent Issued to TriviumVet DAC on April 14 for "Veterinary formulations comprising rapamycin and methods of using the same for treating animal disease" (Irish Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,590, issued on April 14, was assigned to TriviumVet DAC (Waterford, Ireland). "Veterinary formulations comprising rapamycin and methods of... Read More


US Patent Issued to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, THE TEXAS A&M UNIVERSITY SYSTEM on April 14 for "Therapeutic small molecules for treatment of pulmonary hypertension" (Pennsylvania, Texas Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,592, issued on April 14, was assigned to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh) and THE TEXAS... Read More


US Patent Issued to Amicus Therapeutics on April 14 for "Treatment of Fabry disease in ERT-naive and ERT-experienced patients" (Pennsylvania Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,594, issued on April 14, was assigned to Amicus Therapeutics Inc. (Philadelphia). "Treatment of Fabry disease in ERT-naive and ERT-experie... Read More